Anemia classification

 

Anemia Classification: High-Yield Clinical Principles

Anemia is defined as a reduction in total circulating red blood cell (RBC) mass, leading to decreased oxygen-carrying capacity. In clinical practice, anemia is classified using two distinct, complementary systems: Morphological (based on Mean Corpuscular Volume, or MCV) and Kinetic / Pathophysiological (based on the Reticulocyte Production Index, or RPI).

1. The Kinetic Evaluation: Reticulocyte Function

Before categorizing anemia by size, the bone marrow’s functional response must be assessed using the Reticulocyte Count. Because a raw percentage can be falsely elevated in anemia due to a lower total RBC pool, clinicians must utilize the corrected reticulocyte percentage or the Reticulocyte Production Index (RPI):

  • RPI < 2% (Inadequate Bone Marrow Response): Indicates a central production defect. The marrow lacks the raw building blocks (iron, B12/folate) or suffers from structural failure (aplasia, leukemia).
  • RPI > 3% (Adequate Bone Marrow Response): Indicates normal marrow function trying to compensate for peripheral red blood cell loss. This is characteristic of either Hemolysis or Acute Blood Loss.

2. Morphological Classification (Based on MCV)

Dividing anemias by cell size separates them into three main diagnostic pathways based on the normal adult reference range of 80 to 100 fL:

Category (MCV) Core Pathophysiological Mechanism Differential Diagnosis & Clues
Microcytic Anemia
MCV < 80 fL
Decreased production of Hemoglobin. Erythroid precursors undergo extra cell divisions in the marrow, trying to preserve hemoglobin concentration, resulting in smaller cells.
Recall: Hemoglobin = Heme (Iron + Protoporphyrin) + Globin.
Iron Deficiency: Low iron, high TIBC, low ferritin, high RDW.
Anemia of Chronic Disease: High hepcidin traps iron; high ferritin, low TIBC.
Thalassemias: Defective globin chains; normal iron profile, target cells.
Sideroblastic Anemia: Defective protoporphyrin synthesis. Ringed sideroblasts in marrow.
Normocytic Anemia
MCV 80–100 fL
Can represent early stages of micro/macrocytic processes, but classically splits into:
1. Hemolytic / Hemorrhagic states (Peripheral destruction/loss).
2. Underproduction states (Marrow hypoplasia or chronic systemic suppression).
With RPI > 3%: Hemolysis (Intrinsic: Sickle Cell, G6PD, Spherocytosis; Extrinsic: AIHA, MAHA) or Acute Hemorrhage.
With RPI < 2%: Chronic Renal Failure (low EPO), Aplastic Anemia, early Anemia of Chronic Disease.
Macrocytic Anemia
MCV > 100 fL
Divided structurally into:
1. Megaloblastic: Impaired DNA synthesis leads to delayed nuclear maturation relative to cytoplasmic growth.
2. Non-Megaloblastic: Macrocytosis without DNA synthesis impairment.
Megaloblastic: Vitamin B12 or Folate deficiency (hypersegmented neutrophils on smear). B12 features elevated methylmalonic acid (MMA) and neurological symptoms.
Non-Megaloblastic: Chronic alcoholism, liver disease, hypothyroidism. (No hypersegmented neutrophils).

3. Iron Panel Laboratory Breakdown

When confronted with a microcytic anemia, analyzing the iron panel provides immediate differentiation:

Condition Serum Iron Ferritin (Stores) TIBC % Saturation
Iron Deficiency Anemia ↓↓
Anemia of Chronic Disease
Thalassemia Minor Normal / ↑ Normal / ↑ Normal Normal
Sideroblastic Anemia

4. High-Yield Smear Clues & Morphological Variants

  • Red Cell Distribution Width (RDW): RDW measures the variation in RBC size (anisocytosis). It is elevated in Iron Deficiency Anemia as the marrow gradually pumps out smaller and smaller cells, but is typically normal in Thalassemia trait/minor, where cells are uniformly small from birth.
  • Target Cells (Codocytes): Formed due to an excess of cell membrane relative to intracellular hemoglobin volume. Seen characteristically in Thalassemias, Asplenia/Post-Splenectomy, and Hemoglobin C disease.
  • Schistocytes (Helmet Cells): Fragmented red blood cells indicating mechanical shearing. Pathognomonic for Microangiopathic Hemolytic Anemias (MAHA) like TTP, HUS, and DIC, or mechanical disruption from prosthetic heart valves.